LMGAX | Growth Opportunities Fund Class A | Lord Abbett
Image alt tag

Error!

There was a problem contacting the server. Please try after sometime.

Sorry, we are unable to process your request.

Error!

We're sorry, but the Insights and Intelligence Tool is temporarily unavailable

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Error!

We're sorry, but the Literature Center checkout function is temporarily unavailable.

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

Reset Your Password

Financial Professionals*

Your password must be a minimum of characters.

Confirmation Message

Your LordAbbett.com password was successully updated. This page will be refreshed after 3 seconds.

OK

 

Growth Opportunities Fund

Summary

Summary

What is the Growth Opportunities Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of mid-sized U.S. companies.

Fund Basicsas of 10/30/2020

Total Net Assets
$727.83 M
Inception Date
08/01/1995
Dividend Frequency
Annually
Number of Holdings
100
Minimum Initial Investment
$1,000+

Expense Ratioas of 10/31/2020

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 08/01/1995
w/o sales charge 33.63% 35.75% 20.89% 16.53% 13.49% 11.14%
Lipper Category Avg. Multi-Cap Growth Funds - - - - - -
Russell Midcap® Growth Index 29.38% 30.90% 18.84% 17.01% 15.20% 10.54%
w/ sales charge 25.96% 27.96% 18.54% 15.16% 12.82% 10.88%

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 08/01/1995
w/o sales charge 18.00% 28.53% 17.80% 14.70% 13.18% 10.67%
Lipper Category Avg. Multi-Cap Growth Funds 24.15% 35.45% 18.66% 16.90% 14.91% -
Russell Midcap® Growth Index 13.92% 23.23% 16.23% 15.53% 14.55% 10.05%
w/ sales charge 11.23% 21.14% 15.50% 13.35% 12.51% 10.41%

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

RELATED CONTENT

TEN LARGEST HOLDINGS as of 10/30/2020View Portfolio

Holding Assets
Splunk, Inc. 2.5%
RingCentral, Inc. 2.3%
Twilio, Inc. 2.2%
Align Technology, Inc. 2.0%
DocuSign Inc 1.8%
Veeva Systems, Inc. 1.8%
Ball Corp. 1.7%
Chipotle Mexican Grill, Inc. 1.7%
Goosehead Insurance Inc 1.7%
O'Reilly Automotive, Inc. 1.7%

INVESTMENT TEAM

Jeffrey Rabinowitz
Jeffrey Rabinowitz, CFA

Portfolio Manager

21 Years of Industry Experience

Supported By 34 Investment Professionals with 18 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 08/01/1995
w/o sales charge 33.63% 35.75% 20.89% 16.53% 13.49% 11.14%
Lipper Category Avg. Multi-Cap Growth Funds - - - - - -
Russell Midcap® Growth Index 29.38% 30.90% 18.84% 17.01% 15.20% 10.54%
w/ sales charge 25.96% 27.96% 18.54% 15.16% 12.82% 10.88%

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 08/01/1995
w/o sales charge 18.00% 28.53% 17.80% 14.70% 13.18% 10.67%
Lipper Category Avg. Multi-Cap Growth Funds 24.15% 35.45% 18.66% 16.90% 14.91% -
Russell Midcap® Growth Index 13.92% 23.23% 16.23% 15.53% 14.55% 10.05%
w/ sales charge 11.23% 21.14% 15.50% 13.35% 12.51% 10.41%

Fund Expense Ratio :

Gross 1.16%

Net 1.06%

Year Fund Returns Russell Midcap® Growth Index
2019 36.75% 35.47%
2018 -3.36% -4.75%
2017 22.84% 25.27%
2016 1.04% 7.33%
2015 2.68% -0.20%
2014 6.32% 11.90%
2013 37.08% 35.74%
2012 13.81% 15.81%
2011 -10.04% -1.65%
2010 23.26% 26.38%
2009 45.37% -
2008 -38.28% -
2007 21.05% -
2006 7.28% -
2005 4.17% -
2004 11.52% -
2003 33.85% -
2002 -25.25% -
2001 -12.53% -
2000 -3.83% -
Year Q1 Q2 Q3 Q4 Yearly Returns
2020 -19.38% 31.78% 11.06% - 33.54%
2019 19.84% 6.39% -1.52% 8.92% 36.75%
2018 1.77% 2.46% 7.63% -13.89% -3.36%
2017 6.91% 5.17% 4.23% 4.82% 22.84%
2016 -2.11% 2.49% 2.59% -1.83% 1.04%
2015 7.61% 0.91% -7.81% 2.58% 2.68%
2014 1.21% 2.96% -2.83% 5.00% 6.32%
2013 11.24% 2.68% 11.01% 8.11% 37.08%
2012 16.82% -6.25% 4.16% -0.24% 13.81%
2011 7.73% -0.04% -24.99% 11.36% -10.04%
2010 6.64% -13.79% 15.28% 16.29% 23.26%
2009 -2.38% 17.60% 17.52% 7.75% 45.37%
2008 -12.72% 4.39% -12.27% -22.78% -38.28%
2007 4.03% 6.75% 6.77% 2.09% 21.05%
2006 8.76% -5.91% -1.43% 6.35% 7.28%
2005 -2.90% 1.62% 3.59% 1.92% 4.17%
2004 3.07% -0.90% -4.51% 14.34% 11.52%
2003 -0.07% 16.97% 2.07% 12.18% 33.85%
2002 -2.41% -11.08% -16.00% 2.56% -25.25%
2001 -16.71% 14.12% -20.71% 16.05% -12.53%
2000 9.42% -8.90% 1.67% -5.10% -3.83%
1999 -3.83% 12.76% -0.33% 46.21% 58.03%
1998 8.98% 1.09% -20.70% 29.75% 13.36%
1997 0.79% 14.48% 12.78% 0.59% 30.90%
1996 3.24% 2.31% 4.24% 12.30% 23.65%
1995 - - - 5.35% 6.30%

Growth of $10,000 as of 10/31/2020

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 09/30/2020

  • Our investment philosophy is focused on identifying durable franchises that also exhibit a compelling combination of strong growth prospects and seasoned management teams that are mispriced by the market.
  • We believe we can deliver consistently strong returns by owning a portfolio of durable growth companies that have seen growth trends and adoption structurally accelerate supporting current valuation, have developed a stronger competitive position, or have been temporarily negatively impacted by the current environment creating an attractive entry point.
  • We have identified COVID-19 winners that have structurally benefited from the present environment and that we expect will sustain growth. Many of the companies that have been vulnerable during the global pandemic may be  misvalued. We believe many of these companies have been over sold.
  • While we cannot predict the depth and duration of the current crisis, we believe that maintaining a disciplined approach and continuing to execute according to our philosophy and process will serve us well.
  • Furthermore, we believe durable franchises will persevere through challenging environments like we are seeing currently.

PORTFOLIO DETAILS as of 10/30/2020

Total Net Assets
$727.83 M
Number of Holdings
100
Weighted Average Market Cap.
24.0 B
P/B Ratio
8.4x
Portfolio Turnover Ratio as of 11/29/2019
27.1%
P/E Ratio
37.1x

Contributors & Detractors as of  09/30/2020

Contributors

Holding Contribution
Immunomedics, Inc. 1.1%
Peloton Interactive Inc 0.5%
Docusign Inc 0.4%
Natera, Inc. 0.4%
Charles River Laboratories International, Inc. 0.3%

Detractors

Holding Contribution
Slack Technologies Inc -0.2%
BioMarin Pharmaceutical, Inc. -0.2%
Jack Henry & Associates, Inc. -0.2%
Splunk, Inc. -0.1%
RingCentral, Inc. -0.1%

Attribution Analysis 

Growth Opportunities Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 12/03/2020
$0
Dividend Frequency
Annually
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
12/09/1999 12/10/1999 12/17/1999 $0.01270 $19.69

Upcoming Dividend Payment Dates

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
12/17/2020 12/18/2020 12/18/2020

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
12/17/2019 12/18/2019 $1.3500 - $1.3500 $23.69

Upcoming Capital Gain Distribution

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
12/17/2020 12/18/2020

Fees & Expenses

Fees & Expenses

Sales Charge Schedule as of 12/03/2020

  Sales Charge Dealer's Concession Prices at Breakpoint
Less than $50,000 5.75% 5.00% $34.01
$50,000 to $99,999 4.75% 4.00% $33.65
$100,000 to $249,999 3.95% 3.25% $33.37
$250,000 to $499,999 2.75% 2.25% $32.96
$500,000 to $999,999 1.95% 1.75% $32.69
$1,000,000 to $5,000,000 0.00% 1.00% $32.05

EXPENSE RATIOas of 10/31/2020

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
n/a
Prospectus (XBRL)
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Class A  Except as noted below, returns with sales charges reflect a maximum sales charge of 5.75% for equity funds, 2.25% for all tax-free income funds, fixed income funds and multi-asset class funds. There are also ongoing 12b-1 service fees (and, in certain cases, distribution fees).

Class A Shares purchased subject to a front-end sales charge have no contingent deferred sales charge (CDSC). However, certain purchases of Class A shares made without a front-end sales charge may be subject to a CDSC of 1% if the shares are redeemed before the first day of the month in which the one year anniversary of the purchase falls. The CDSC is not reflected in the performance with maximum sales charge.

Except as noted below, returns with sales charges reflect a maximum sales charge of 2.50%. There are also ongoing 12b-1 service and distribution fees.

Class A Shares purchased subject to a front-end sales charge have no contingent deferred sales charge (CDSC). However, certain purchases of Class A shares made without a front-end sales charge may be subject to a CDSC of 1.50% if the shares are repurchased before the first day of the month in which the one year anniversary of the purchase falls. The CDSC is not reflected in the performance with maximum sales charge.

 

Except as noted below, returns with sales charges reflect a maximum sales charge of 2.50%. There are also ongoing 12b-1 service and distribution fees.

Class A Shares purchased subject to a front-end sales charge have no contingent deferred sales charge (CDSC). However, certain purchases of Class A shares made without a front-end sales charge may be subject to a CDSC of 1.50% if the shares are repurchased before the first day of the month in which the one year anniversary of the purchase falls. The CDSC is not reflected in the performance with maximum sales charge.

The Russell Midcap® Growth Index measures the performance of those Russell Midcap companies with higher price-to-book ratios and higher forecasted growth values. The stocks are also members of the Russell 1000 Growth index.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field